PH12018500304A1 - A delyade release drug formulation - Google Patents

A delyade release drug formulation

Info

Publication number
PH12018500304A1
PH12018500304A1 PH12018500304A PH12018500304A PH12018500304A1 PH 12018500304 A1 PH12018500304 A1 PH 12018500304A1 PH 12018500304 A PH12018500304 A PH 12018500304A PH 12018500304 A PH12018500304 A PH 12018500304A PH 12018500304 A1 PH12018500304 A1 PH 12018500304A1
Authority
PH
Philippines
Prior art keywords
polymeric material
drug
core
inner layer
layer comprises
Prior art date
Application number
PH12018500304A
Other versions
PH12018500304B1 (en
Inventor
Gonzalez Roberto Carlos Bravo
Thomas Buser
Frederic Jean-Claude Goutte
Abdul Waseh Basit
Felipe Jose Oliveria Varum
Ana Cristina Freire
Original Assignee
Tillotts Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP12166110.2A external-priority patent/EP2659881B1/en
Application filed by Tillotts Pharma Ag filed Critical Tillotts Pharma Ag
Publication of PH12018500304A1 publication Critical patent/PH12018500304A1/en
Publication of PH12018500304B1 publication Critical patent/PH12018500304B1/en

Links

Abstract

Delayed release of a drug to the colon is achieved from a delayed release formulation comprising a core and a coating for the core. The core comprises a drug and the coating comprises an inner layer and an outer layer. The outer layer comprises a mixture of a first polymeric material which is susceptible to attack by colonic bacteria, and a second polymeric material which has a pH threshold at about pH 5 or above. The inner layer comprises a third polymeric material which is soluble in intestinal fluid or gastrointestinal fluid, said third polymeric material being selected from an at least partially neutralised polycarboxylic acid and a non-ionic polymer. In embodiments in which the third polymeric material is a non-ionic polymer, the inner layer comprises at least one of a buffer agent and a base. Advantages of formulations according to the present invention include accelerated release of the drug when exposed to colonic conditions and reduction or elimination of a food and/or alcohol effect on drug release after administration.
PH12018500304A 2012-04-30 2018-02-12 A delayed release drug formulation PH12018500304B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261640217P 2012-04-30 2012-04-30
EP12166110.2A EP2659881B1 (en) 2012-04-30 2012-04-30 A delayed release drug formulation
PCT/EP2013/058921 WO2013164315A1 (en) 2012-04-30 2013-04-29 A delayed release drug formulation

Publications (2)

Publication Number Publication Date
PH12018500304A1 true PH12018500304A1 (en) 2018-09-24
PH12018500304B1 PH12018500304B1 (en) 2018-09-24

Family

ID=54196716

Family Applications (3)

Application Number Title Priority Date Filing Date
PH12017502369A PH12017502369A1 (en) 2012-04-30 2017-12-20 A delayed release drug formulation
PH12018500304A PH12018500304B1 (en) 2012-04-30 2018-02-12 A delayed release drug formulation
PH12018501311A PH12018501311A1 (en) 2012-04-30 2018-06-19 A delayed release drug formulation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PH12017502369A PH12017502369A1 (en) 2012-04-30 2017-12-20 A delayed release drug formulation

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH12018501311A PH12018501311A1 (en) 2012-04-30 2018-06-19 A delayed release drug formulation

Country Status (10)

Country Link
JP (2) JP6700220B2 (en)
CL (2) CL2017001990A1 (en)
CU (2) CU24343B1 (en)
CY (1) CY1121470T1 (en)
EC (2) ECSP14028079A (en)
HK (3) HK1202267A1 (en)
HR (3) HRP20190470T1 (en)
IL (2) IL235282A (en)
PH (3) PH12017502369A1 (en)
ZA (1) ZA201407675B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3662902A1 (en) * 2018-12-07 2020-06-10 Tillotts Pharma AG Colonic drug delivery formulation
EP3662900A1 (en) * 2018-12-07 2020-06-10 Tillotts Pharma AG Colonic drug delivery formulation
CN113493220A (en) * 2020-04-02 2021-10-12 杨洋 Hollow metal oxide microsphere, preparation method thereof and drug sustained-release application

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422121A (en) * 1990-11-14 1995-06-06 Rohm Gmbh Oral dosage unit form
BRPI0721654B8 (en) * 2007-05-07 2022-07-05 Evonik Roehm Gmbh solid dosage forms comprising an enteric coating with accelerated drug release, their method of manufacture and use
SI2659881T1 (en) * 2012-04-30 2018-03-30 Tillotts Pharma Ag A delayed release drug formulation

Also Published As

Publication number Publication date
JP6700220B2 (en) 2020-05-27
CY1121470T1 (en) 2020-05-29
IL235282A (en) 2017-09-28
PH12017502369A1 (en) 2020-09-28
CL2017001990A1 (en) 2018-03-16
HRP20190470T1 (en) 2019-05-17
HRP20192210T1 (en) 2020-02-21
JP2017145268A (en) 2017-08-24
ECSP14028079A (en) 2015-12-31
HK1202267A1 (en) 2015-09-25
IL235283A (en) 2017-09-28
CU24343B1 (en) 2018-05-08
CU20160014A7 (en) 2016-04-25
HRP20190727T1 (en) 2019-06-14
JP2017145267A (en) 2017-08-24
CU24342B1 (en) 2018-05-08
CU20160026A7 (en) 2016-05-30
HK1202266A1 (en) 2015-09-25
JP6626470B2 (en) 2019-12-25
PH12018501311A1 (en) 2020-09-14
PH12018500304B1 (en) 2018-09-24
ZA201407675B (en) 2016-05-25
HK1244435B (en) 2019-10-25
ECSP14028077A (en) 2015-12-31
CL2017001989A1 (en) 2018-03-16

Similar Documents

Publication Publication Date Title
PH12014502340A1 (en) A delayed release drug formulation
PH12016500307B1 (en) A delayed release drug formulation
PH12018500304A1 (en) A delyade release drug formulation
CU20140124A7 (en) FORMULATION OF DELAYED RELEASE DRUG